| CAT # | Product Name | Tsanangudzo |
| CPD100230 | JBJ-04-125-02 R-isomer | |
| CPD3232 | NTN21277 | NTN21277, inozivikanwawo seGefitinib-based PROTAC 3 inonzi VHL-recruiting PROTAC inokonzera kusvibiswa kweEGFR neEGFR mutants ine DC50 ye11.7 nM uye 22.3 nM yeHCC827 cell (Exon 19 del) uye H3255R cell (L8255R). |
| CPDB3615 | Nazartinib; EGF816; NVS-816 | Nazartinib, inozivikanwawo seEGF816 uye NVS-816, inowanikwa nemuromo, isingadzokerike, yechitatu-chizvarwa, inosarudzika epidermal growth factor receptor (EGFR) inhibitor, ine inogona kuita antineoplastic. |
| CPDB0934 | EAI-045 | EAI045 ia ine simba uye inosarudza EGFR inhbitor. EAI045 inonangwa yakasarudza EGFR isingaite mushonga asi inochengetedza mhuka yemusango inogamuchira. EAI045 inhibits L858R/T790M-mutant EGFR ine yakaderera-nanomolar potency mu biochemical assays. |
| CPDB0101 | Poziotinib | Magadzirirwo ane poziotinib ari pasi pekuongororwa mumakiriniki ekuedzwa kwekurapa kweEGFR-mutant lung adenocarcinoma. |
| CPDB0137 | Osimertinib Mesylate | Osimertinib, inozivikanwawo semereletinib uye AZD-9291, chizvarwa chechitatu cheEGFR inhibitor, yakaratidza chivimbiso muzvidzidzo zvepakutanga uye inopa tariro kune varwere vane kenza yemapapu yepamusoro iyo yave isingagadziriki kune EGFR inhibitors iripo. |
